| Literature DB >> 28191499 |
Madison Miller1, Nitin Shirole2, Ruxiao Tian1, Debjani Pal3, Raffaella Sordella2.
Abstract
As the most mutated gene in cancer, it is no surprise that TP53 has been the center of cancer biology discourse since its discovery in the late 1970s. Although early demonstrations of p53's role in the modulation of cell proliferation and survival solidified its classification as a tumor suppressor and transcription factor, our conceptualization of p53 is ever-evolving. Here, we present novel evidence of the role of alternative splicing isoforms, truncating/separation-of-function mutations, and hotspot silent mutations in the regulation of p53's activities.Entities:
Keywords: Alternative splicing; Gain-of-function; Hot-spot mutations; Loss-of-function; Separation-of-function; Silent mutations; Truncating mutations; p53; p53 isoforms; p53-psi
Year: 2016 PMID: 28191499 PMCID: PMC5298884
Source DB: PubMed Journal: J Cancer Biol Res ISSN: 2373-9436